|
Originally published In Press as doi:10.1074/jbc.M111500200 on December 18, 2001
J. Biol. Chem., Vol. 277, Issue 10, 8217-8225, March 8, 2002
The Prosequence of Human Lactase-Phlorizin Hydrolase Modulates
the Folding of the Mature Enzyme*
Ralf
Jacob,
Karen
Peters, and
Hassan Y.
Naim
From the Department of Physiological Chemistry, School of
Veterinary Medicine Hannover, Bünteweg 17, Hannover D-30559,
Germany
Received for publication, December 3, 2001, and in revised form, December 10, 2001
 |
ABSTRACT |
The efficient transport of proteins along the
secretory pathway requires that the polypeptide adopts a stably folded
conformation to egress the endoplasmic reticulum (ER). The
transport-competent precursor of the brush border enzyme LPH, pro-LPH,
undergoes an intracellular cleavage process in the
trans-Golgi network between Arg734 and
Leu735 to yield LPH initial. The role of the
prodomain comprising the N-terminally located 734 amino acids of
pro-LPH, LPH , in the folding events of LPH initial has
been analyzed by the individual expression of both forms in COS-1
cells. Following synthesis at 37 °C LPH initial
acquires a misfolded and enzymatically inactive conformation that is
degraded by trypsin. A temperature shift to 20 °C generates a
stable, trypsin-resistant, and enzymatically active
LPH initial indicating that the individual expression of LPH initial results in a temperature-sensitive
conformation. This form interacts at non-permissive temperatures
sequentially with the ER chaperones immunoglobulin-binding
protein and calnexin resulting in an ER retention. The LPH
prodomain resides in the ER when individually expressed. It reveals
compact structural features that are stabilized by disulfide bridges.
LPH and LPH initial readily interact with each other
upon coexpression, and this interaction appears to trigger the
formation of a trypsin-resistant, correctly folded, enzymatically
active, and transport-competent LPH initial polypeptide.
These data clearly demonstrate that the proregion of pro-LPH is an
intramolecular chaperone that is critically essential in facilitating
the folding of the intermediate form LPH initial in the
context of the pro-LPH polypeptide.
 |
INTRODUCTION |
The endoplasmic reticulum
(ER1) is the fabric in which
newly synthesized membrane-bound and secretory proteins are extensively processed and shaped to attain a competent mobility within the cell and
to achieve a functional maturation. A considerable number of pivotal
modification reactions commence already during the translocation of the
extending polypeptide across the ER and facilitate ultimately the
folding of the protein into a native conformation (for review see Ref.
1). Examples are signal sequence cleavage from the nascent polypeptide
chain (2), cotranslational core N-glycosylation at
particular Asn residues belonging to the sequon (Asn-X-Ser/Thr) (3), disulfide bond formation (4), and
transient interactions of the folding polypeptide with a set of ER
resident accessory proteins, such as molecular chaperones (5, 6). In
the lumen of the ER, proteins assume their secondary and tertiary structures and, in the case of multisubunit polypeptides, assemble their individual subunits into heterodimeric, homodimeric, or larger
order complexes (7). Essentially only correctly folded and assembled
proteins can egress the ER and continue their further journey along the
secretory pathway. The conformational status of newly synthesized
polypeptides is monitored in the lumen of the ER by an efficient
quality control mechanism (8). Proteins that fail to acquire a correct
three-dimensional structure are retained in the ER and ultimately
degraded, presumably in the cytosol by the ER-associated
ubiquitin-proteasome pathway (9). Increasing evidence points to the
possible existence of a monitoring system that operates beyond the ER.
A naturally occurring mutant of intestinal sucrase-isomaltase
(10) or a temperature-sensitive mutant of the G protein of vesicular
stomatitis virus (11) exit the ER but are blocked in a pre-Golgi
compartment instead of transported further to their final destination,
the cell surface. The acquisition of a protein to a configuration
similar to that of the mature and biologically active species does not
always constitute an absolute requirement for its transport along the
secretory pathway to the final destination. Nevertheless, retarded
transport kinetics and impaired function are frequently the
consequences of altered protein folding as has been demonstrated for
some mutants of the hemagglutinin of the influenza virus (12) and
deletion mutants of intestinal lactase-phlorizin hydrolase (13, 14).
Presumably, for some proteins only correct folding of particular
subdomains is adequate for their mobility along the secretory pathway.
It is conceivable that the structural features of the protein
critically determine whether or not a protein is retained in the ER by
binding specific chaperones if it did not fulfill particular folding criteria.
Several proteins possess proregions or propeptides at the N-terminal
end, which undergo cleavage during or after maturation of the precursor
polypeptide. Cleavage of these propeptides is associated in many cases
with biological activation of the final mature form of the protein (15)
as in the cases of zymogens, neuropeptides, and prohormones (16). An
important function of propeptides is that of an intramolecular
chaperone that regulates and affects the folding of the precursor
protein. A well-studied example is subtilisin. The propeptide of this
protein comprises 77 amino acids and is critically important for the
folding of the remaining 275 amino acids that constitute the mature and
active protein (17). Human small intestinal lactase-phlorizin hydrolase (LPH, EC 3.2.1.23-62), an important component of the brush-border membrane, comprises a relatively large proregion (LPH ) that accounts for about 45% of the precursor molecule (prepro-LPH, 1927 amino acids)
(18) and a brush-border mature polypeptide, LPH . Initial studies
have demonstrated that LPH is synthesized as a single-chain polypeptide
precursor, prepro-LPH, that undergoes two sequential intracellular
cleavage steps: the first in the ER to pro-LPH (215-kDa) and the
second, following terminal glycosylation in the Golgi apparatus, to a
160-kDa LPH (19-21). Based on sequence analyses of various
biosynthetic forms of LPH, recent studies have provided an unequivocal
evidence for the existence of an additional cleavage step occurring
extracellularly in the intestinal lumen (22, 23). Thus, the initial
cleavage step of complex-glycosylated pro-LPH takes place at residues
Arg734/Leu735, implicates a trypsin-like
protease, and generates an LPH polypeptide encompassing residues
735-1927 (23) that was denoted LPH initial (24). The
LPH initial molecule is subsequently targeted to the brush-border membrane where a final digestion by luminal trypsin occurs
at Arg868/Ala869, which eliminates a peptide
stretch from residues Leu735 to Arg868 yielding
LPH final (22, 23). This form is the polypeptide that
exerts its enzymatic function as a -galactosidase in the small
intestine. The cleavage of pro-LPH to LPH initial and its potential implications on the function and trafficking on this form has
been studied in heterologous transfection systems. Meanwhile it has
become clear that uncleaved pro-LPH is a transport-competent (25), a
correctly sorted (26, 27), and an enzymatically active molecule (25),
and hence cleavage of pro-LPH in intestinal cells is neither required
for activation of the enzyme, nor is it implicated in the transport and
sorting events. LPH initial contains all the information
needed for apical sorting of pro-LPH, whereas LPH is devoid of
sorting signals despite striking sequence homologies shared with
LPH initial (18). Moreover, the LPH profragment is
devoid of catalytic activity, because the lactase and phlorizin
hydrolase activities have been assigned to glutamates 1271 and 1747 of
LPH final, respectively (28), and, moreover, the
activities of the precursor pro-LPH and LPH final are
identical (25) for lactose or phlorizin hydrolysis.
Based on the initial concepts that pro-LPH is immediately
cleaved at the Arg868/Ala869 site a cDNA
clone encoding the polypeptide Ala869-Phe1927,
LPH final, was expressed individually in the absence of
the profragment, and its biosynthetic and structural features were analyzed. It was shown that the polypeptide generated was an
enzymatically inactive protein, and most of it was retained as a
mannose-rich glycosylated indicative of a predominant ER localization.
This has lead to the hypothesis that the profragment LPH functions as an intramolecular chaperone that is implicated in the folding of the
LPH domain in the ER (29, 30). The intestinal form of LPH is
neither N- nor O-glycosylated, despite the
presence of five potential N-glycosylation sites, and is
rich in cysteine and hydrophobic amino acid residues. These features
have suggested that LPH folds rapidly into a tight and rigid
globular domain in which carbohydrate attachment sites are no longer
accessible to glycosyltransferases. In this paper we investigate the
folding features of LPH and LPH initial and the
putative role of LPH as an intramolecular chaperone. Additionally,
in view of the new constellation that the initial cleavage occurs at
Arg734/Leu735 rather than at
Arg868-Ala869, it became important to determine the
role of the polypeptide stretch Leu735-Arg868
in the processing and folding within the pro-LPH species.
 |
EXPERIMENTAL PROCEDURES |
Materials and Reagents--
Tissue culture dishes were obtained
from Greiner, Hamburg, Germany. Streptomycin, penicillin, glutamine,
Dulbecco's modified Eagle's medium (DMEM), methionine-free DMEM
(denoted Met-free medium), and trypsin were purchased from Invitrogen,
Eggenstein, Germany. Fetal calf serum, pepstatin, leupeptin, aprotinin,
trypsin inhibitor, and molecular mass standards for SDS-PAGE were
purchased from Sigma Chemical Co., Deisenhofen, Germany.
Phenylmethylsulfonyl fluoride, antipain, and soybean trypsin inhibitor
were obtained from Roche Diagnostics (Mannheim).
L-[35S]Methionine (>1000 Ci/mmol) and
protein A-Sepharose were obtained from Amersham Biosciences, Inc.,
Freiburg, Germany. Acrylamide, N,N'-methylenebisacrylamide, and TEMED were
purchased from Carl Roth GmbH, Karlsruhe, Germany. SDS, ammonium
persulfate, dithiothreitol, and Triton X-100 (TX-100) were obtained
from Merck, Darmstadt/Germany. Endo- -acetylglucosaminidase H (endo
H) and endo- -N-acetylglucosaminidase F/N-glycosidase F (endo F/GF) were purchased from New
England BioLabs, Frankfurt, Germany. The pEYFP-N1 and pECFP-N1 vectors were purchased from CLONTECH Laboratories, Inc,
Heidelberg, Germany. Restriction enzymes and T4-DNA-Ligase were
obtained from MBI Fermentas, St. Leon-Rot, Germany.
Immunochemical Reagents--
For immunoprecipitation of human
LPH mouse monoclonal antibodies (mAb) of hybridoma HBB 1/909 (20) and
MLac 2, MLac 6, and MLac 8 (31) were used. The antibodies were generous
gifts of Dr. Hans-Peter Hauri (Biozentrum, Basel, Switzerland), Dr.
Erwin Sterchi (University of Bern, Switzerland), and Dr. Dallas Swallow (Medical Research Council, London, UK). LPH was precipitated with
the polyclonal antibody V496 directed against the N-terminal part of
the prodomain (30). Anti-BiP and anti-calnexin antibodies were generous
gifts from Dr. Neil Bulleid, University of Manchester, UK.
Construction of cDNA Clones--
LPH initial
was cloned in two steps. First, the cDNA encoding the signal
sequence of pro-LPH, LPHsignal, was amplified by PCR as
described before (30). A second part of the cDNA comprising the
last 20 nucleotides of the LPH signal sequence (nucleotides 52-71) and
nucleotides 2203-3572 of LPH initial was synthesized by
PCR using LPHcDNA as template and the oligonucleotides LPHsig/beta (GTT TTT CAT GCT GGG GGT CAC TGT TGC AGT TTG TAT CCC T) and cLPH3600 (25). Both DNA fragments were then fused by assembly PCR and cloned
with the 3'-EcoRI/HindIII fragment of LPH
cDNA into the unique EcoRI site of the pJB20 expression
vector (27) by a three-way ligation. The resulting construct denoted
pJB20-LPH initial was sequenced and found to contain the
signal sequence of pro-LPH fused in-frame to the cDNA beginning
with nucleotide 2203. For the generation of a CFP fusion protein
the EcoRI/ScaI fragment of
pJB20-LPH initial was subcloned into the
EcoRI/SmaI-digested pECFP-N1 vector
(CLONTECH, Inc., Heidelberg, Germany) to generate pLPH initial-CFP.
The profragment of pro-LPH, LPH , extending to nucleotide 2202 was
first amplified from the LPHcDNA template by PCR with the primer
pair LPH1 (25)/cLPH (AAT CTA GAG CCT CCT TAT CCC CCA G), which
inserts a stop codon at position 2203 in the LPH cDNA. This DNA
fragment was inserted into the unique EcoRI/XbaI
sites of pcDNA3 (Invitrogen, Groningen, The Netherlands). The
resulting construct, pcDNA3-LPH , was confirmed by sequencing.
LPH and YFP were fused by PCR amplification of LPH using
full-length LPHcDNA as template with the primer pair
LPH1HindIII (AAA AGC TTC CTA GAA AAT GGA GCT G)/cLPH
SalI (CCT CGT CGA CCT CCT TAT CCC CCA GGG) and ligation of
the PCR product into the HindIII/SalI sites of
pEYFP-N1. The generated plasmid was confirmed by sequencing and named
pLPH -YFP.
Transient Transfection of COS-1 Cells, Biosynthetic Labeling, and
Immunoprecipitation--
COS-1 cells were transiently transfected with
DNA by using DEAE-dextran essentially as described previously (25).
pJB20-LPH initial, pcDNA3-LPH , or a mixture of
both plasmids, pLPH -YFP and pLPH initial-CFP, were
used. 48 h after transfection, the cells were biosynthetically labeled. Here, the cells were preincubated with 5 ml of methionine-free MEM for 1 h after which time the medium was changed and replaced by a similar medium containing 50 µCi of
[35S]methionine. Labeling was performed for 1 h
followed by a chase with non-labeled methionine for 4 h. After
labeling, the cells were rinsed twice with cold phosphate-buffered
saline and solubilized with 1 ml of lysis buffer containing 25 mM Tris-HCl (pH 8.0), 50 mM NaCl, 0.5% sodium
deoxycholate, and 0.5% TX-100 supplemented with 1 mM phenylmethylsulfonyl fluoride, 1 µg/ml pepstatin, 5 µg/ml leupeptin, 5 µg/ml aprotinin, 1 µg/ml antipain, and 50 µg/ml trypsin inhibitor for 30 min at 4 °C. The cell extracts were
centrifuged to remove cell debris while the supernatant was retained
for the subsequent immunoprecipitation. After 1 h of preclearing
with 20 µl of protein A-Sepharose, the immunoprecipitation was
performed with polyclonal anti-LPH (V496) or a mixture of mAb
anti-LPH (MLac 2, MLac 6, and MLac 8) and 50 µl of protein
A-Sepharose as described previously (13). For assessment of the
interaction of the various LPH initial forms with BiP or
calnexin, the cellular extracts were immunoprecipitated with mAb
anti-BiP or mAb anti-calnexin (32). The immunoprecipitates were eluted
by boiling in 1% SDS for 10 min followed by 10-fold dilution of SDS
using a buffer containing 1% Triton X-100. Thereafter the samples were
immunoprecipitated with a mixture of anti-LPH antibodies directed
against native and denatured forms of the protein. The
immunoprecipitates were further processed on SDS-PAGE.
Trypsin Treatment of Cell Lysates--
LPH initial
was immunoprecipitated from transient transfected COS-1 cells labeled
with [35S]methionine for 6 h. The immunoprecipitates
were treated with 50 µg/ml trypsin for the indicated times at
37 °C. The reaction was stopped by the addition of 2 mg/ml soybean
trypsin inhibitor (Roche Molecular Biochemicals, Mannheim, Germany).
Cell-free Transcription/Translation--
The vector
pcDNA3-LPH containing the profragment of human pro-LPH was
linearized with ApaI. Transcription was initiated with T7-RNA polymerase and carried out essentially as described before (32).
Subsequently, the mixture was extracted once with phenol/chloroform and
twice with chloroform. After ethanol precipitation, the RNA was
resuspended in 50 µl of RNase-free water. Translation of the newly
synthesized RNA was performed in nuclease-treated rabbit reticulocyte
lysate. The reaction mixture comprised 18 µl of reticulocyte lysate,
1 µl of 1 mM amino acids (minus methionine), 15 µCi of L-[35S]methionine, and 3 µl of transcribed
RNA. Where indicated, the samples were supplemented with 1 µl of
nuclease-treated microsomal membranes. Translations were performed in
the absence or presence of 2 or 6 mM oxidized glutathione
(GSSG) at 30 °C for 60 min. Microsomal membranes were isolated as
described by Bulleid and Freedman (33). Samples were prepared for
electrophoresis by mixing with 5 vol. of SDS-PAGE sample buffer (62.5 mM Tris-HCl, pH 6.8, SDS (2% w/v), glycerol (10% w/v),
and bromphenol blue) in the presence of 50 mM
dithiothreitol for reducing conditions and for non-reducing conditions
in the presence of 100 mM iodoacetamide and boiled for 5 min. After electrophoresis, gels were processed for autoradiography and
exposed to Kodak X-Omat AR film.
Confocal Fluorescence Microscopy--
Confocal images of living
cells were acquired 2 days after transfection on a Leica TCS SP2
microscope with a ×63 water planapochromat lens (Leica Microsystems)
(34). Dual color CFP and YFP images were obtained by sequential scans
with the 458- and 514-nm excitation lines of an argon laser and the
optimal emission wavelength for CFP or YFP, respectively.
Enzymatic Assays--
Lactase activity was measured according to
Dahlqvist (35) using lactose as substrate. LPH initial
was immunoprecipitated from cell lysates of transiently transfected
COS-1 cells. For each determination of the lactase activity, the lysate
equivalent to fourteen 100-mm-diameter dishes of confluent cells
was utilized. The immunoprecipitates were subsequently assayed for
lactase activity essentially as described (25).
Other Procedures--
Digestion of 35S-labeled
immunoprecipitates with endo- -N-acetylglucosaminidase H
(endo H) and endo- -N-acetylglucosaminidase F/glycopeptidase F (endo F/GF) was performed as previously described (21). Neuraminidase treatment of immunoprecipitates was performed in 20 mM sodium citrate, 20 mM Tris-malate buffer (pH
6.0) and protease inhibitors for 2 h at 37 °C essentially as
described by Jacob et al. (27).
 |
RESULTS |
The LPH initial Polypeptide Is a
Temperature-sensitive Folding Mutant--
The cDNA encoding the
initial cleavage product, LPH initial
(Leu735-Phe1927) was fused to the signal
sequence of pro-LPH to allow translocation across the ER membrane (Fig.
1). Expression of this hybrid form in
COS-1 cells and assessment of its glycosylation pattern using endo H
sensitivity revealed a strongly labeled 150-kDa mannose-rich polypeptide (LPH initial/h) in addition to a 175-kDa endo
H-resistant complex protein (LPH initial/c). The
proportions of these two forms at steady state demonstrated a
predominant presence of the mannose-rich protein with ~70% of the
total LPH initial protein. When LPH final
was expressed individually the amount of complex-glycosylated LPH final was substantially reduced (30) suggesting a
role of the Leu735-Arg866 stretch in the
processing of LPH initial. Nevertheless, the processing of mannose-rich LPH initial (LPH initial/h)
to the complex-glycosylated form (LPH initial/c) was
markedly less efficient in comparison with that of wild type pro-LPH
(Fig. 2A) pointing to an
altered folding pattern of LPH in the absence of the profragment.
The enzymatic activity of lactase has been assigned to residues
Glu1273 and Glu1749 within the
LPH initial domain (36). Individual expression of this
domain is associated with a drastic reduction in the lactase activity
(Table I) reminiscent of a misfolded
structure of LPH initial at least at or in the vicinity
of the catalytic site. However, the partial conversion of
LPH initial from a mannose-rich polypeptide into a
complex-glycosylated protein suggests that a proportion of the
LPH initial protein has acquired a correct conformation albeit at a slower rate. Alternatively, minimal folding requirements of
LPH initial were fulfilled permitting the partially
folded protein to egress the ER. We wanted therefore to determine
whether slowing down the processing rate of LPH initial
and prolonging its residence time in the ER influences the structural
features of LPH initial and its biological activity. For
this purpose, cells transfected with the cDNA encoding
LPH initial were labeled biosynthetically at 20 °C.
Fig. 2B shows that the mannose-rich polypeptide was
converted to a complex-glycosylated protein after 8 h of chase.
Interestingly, this protein was now as enzymatically active as its wild
type pro-LPH counterpart (Ref. 25 and Table I). We next compared the
fate of LPH initial under the two different labeling
temperatures by employing a pulse-chase protocol. Here, a dramatic
difference in the turnover rates was observed. Although LPH initial was gradually degraded with increasing chase
periods at 37 °C, longer chase periods of up to 24 h at
20 °C have resulted in an efficient conversion of mannose-rich
LPH initial/h to a meanwhile predominantly labeled
complex-glycosylated LPH initial/c.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 1.
Schematic representation of the structure of
pro-LPH in human small intestinal cells and the two constructs
LPH initial and
LPH . Some important structural features
of pro-LPH in human small intestinal cells. Shown is the cleavable
sequence (Met1-Gly19) at the N terminus. The
ectodomain encompasses amino acid residues Ser20 to
Thr1882. The intracellular proteolytic cleavage takes place
between Arg734 and Leu735 to generate
LPH initial. The luminal extracellular cleavage occurs at
Arg868 to generate the brush-border mature enzyme,
LPH final (Arg868-Phe1927) (22,
23). The construct LPH initial was generated by fusing
the 19 amino acids of the LPH signal sequence to Leu735,
the N terminus of LPH initial. For expression of LPH ,
a stop codon was introduced after Arg734. MA,
membrane anchoring; CT, cytoplasmic tail.
|
|

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 2.
Biosynthesis and transport kinetics of
LPH initial in COS-1 cells.
A, COS-1 cells were transiently transfected with
pJB20-LPH initial, biosynthetically labeled for 6 h
followed by immunoprecipitation of LPH initial. The
immunoprecipitates were divided into three aliquots and treated with
endo H, endo F/GF, or not treated. The proteins were subjected to
SDS-PAGE and autoradiography. B, transiently transfected
COS-1 cells were pulsed with [35S]methionine for 1 h
at 37 °C followed by different chase times at 20 °C or 37 °C.
Cells were lysed, and the immunoprecipitates were analyzed by SDS-PAGE
and autoradiography. C, immunoprecipitates of transiently
transfected COS-1 cells incubated at 20 °C or 37 °C were loaded
onto SDS-PAGE followed by Coomassie Blue staining of the gel.
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Enzymatic activity of LPH initial in transfected COS cells
COS-1 cells were transiently transfected with
pJB20-LPH initial alone or in combination with
pcDNA3-LPH and incubated at 37 °C for 48 h. Following
cell lysis LPH initial was immunoprecipitated and the lactase
activities in the immunoprecipitates were measured according to
Dahlqvist (35). Results are the mean ± S.E. of
three experiments.
|
|
This increase in stability of LPH initial after synthesis
at 20 °C was also observed by determination of the steady-state level of the polypeptide after synthesis at 37 °C or 20 °C in a
Coomassie Blue-stained polyacrylamide gel (Fig. 2C). In
these experiments LPH initial/h was isolated from
transfected COS cells incubated at 37 °C, whereas
LPH initial/c was detected in cells cultured at 20 °C.
This indicates that reduced temperatures facilitate the formation of a
stable conformation of complex-glycosylated LPH initial/c. A direct comparison of the forms generated
at the two different temperatures reveals an increase of ~10 kDa in
the apparent molecular mass of LPH initial/c
formed at 37 °C as compared with the isoform at 20 °C (Fig.
3A). One possible explanation for this difference could be altered sugar contents in both forms. To
determine this content, pulse-chase experiments, with
transfected cells at 37 °C or 20 °C combined with deglycoslyation
of the LPH initial isoforms with neuraminidase and endo
F/GF, were performed (Fig. 3A). At 4 h of chase the
mannose-rich glycosylated LPH initial/h was
immunoprecipitated from the cell lysates, which was sensitive to endo
F/GF and expectedly devoid of sialic acid as assessed by its
insensitivity to neuraminidase treatment. Within 12 h of chase
complex-glycosylated LPH initial/c appeared and shifted to 155 kDa after desialylation with neuraminidase. Neuraminidase also
reduces LPH initial/c synthesized at 37 °C to the
155-kDa polypeptide. Therefore, the difference in the apparent
molecular masses of the LPH initial at both temperatures
is due to a variable content of terminal sialic acid residues. To
analyze if this difference in glycosylation of
LPH initial/c has any influence on or is related to
changes in the folding and stability of the protein, we probed its
sensitivity toward trypsin. Correctly folded wild type brush-border LPH is resistant to trypsin treatment (25). Changes in the protein
folding of LPH initial would be therefore monitored by variation in its susceptibility to trypsin. As shown in Fig.
3B, trypsin resulted in a drastic degradation of
LPH initial/h and LPH initial/c, which were
synthesized at 37 °C. After 5 min of incubation with trypsin, almost
all of the LPH initial was degraded. By contrast,
LPH initial synthesized and processed at 20 °C was resistant to trypsin. It is worthwhile to note that a minor proportion of LPH initial synthesized at 37 °C was resistant to
trypsin, and, interestingly enough, this proportion had a similar
apparent molecular mass as the correctly folded
LPH initial synthesized at 20 °C. The acquisition of
trypsin resistance at 20 °C similar to the wild type enzyme strongly
suggests that LPH initial exhibits characteristics of a
temperature-sensitive protein in the absence of the LPH profragment.
The variation in the folding pattern observed at 37 °C is also
associated with an altered terminal glycosylation pattern.

View larger version (47K):
[in this window]
[in a new window]
|
Fig. 3.
Processing and folding of
LPH initial at 20 °C.
A, COS-1 cells were transiently transfected with
pJB20-LPH initial, biosynthetically labeled at 20 °C
for 4 h, and chased for the indicated times or labeled at 37 °C
with [35S]methionine for 2 h followed by a 12-h
chase. After cell lysis LPH initial was
immunoprecipitated and the immunoprecipitates were divided into equal
aliquots and treated with endo F/GF, neuraminidase, or not treated. The
proteins were subjected to SDS-PAGE and autoradiography. B,
trypsin sensitivity assay of LPH initial. Transiently
transfected COS-1 cells were biosynthetically labeled at 37 °C for
8 h or at 20 °C for 12 h followed by immunoprecipitation
of LPH initial from the cell lysates. The
immunoprecipitates were treated with trypsin for different times and
analyzed on SDS-PAGE. The trypsin-sensitive form of
LPH initial/c detected after synthesis at 37 °C is
indicated by asterisks.
|
|
LPH Alone Is a Compact Globular Polypeptide--
Obviously the
presence of the LPH profragment is crucial in influencing the
folding of LPH initial in the context of wild type
pro-LPH. It has been previously postulated that the LPH molecule,
which contains 11 cysteine residues, attains a compact structure that
is stabilized by disulfide bridges and that acts as a kernel for the
folding of the mature enzyme (30). To characterize the role of this
domain in this context, we assessed its structural features in an
in vitro translation assay. The cDNA encoding LPH was
transcribed in vitro and translated with rabbit reticulocyte lysate supplemented with dog pancreatic microsomal vesicles. This system has already been used to demonstrate the presence of disulfide bridges in the full-length pro-LPH enzyme (32). The main polypeptide synthesized in the absence of added microsomal vesicles had an apparent
molecular mass of 90 kDa (Fig.
4A) consistent with the molecular weight of LPH calculated from the deduced amino acid sequence (18). In the presence of microsomal membranes an additional polypeptide of 100 kDa was generated. Separation of the microsomal membranes from the reticulocyte lysates by centrifugation through a
sucrose cushion revealed a predominant labeling of this species in the
microsomal membranes. The 100-kDa protein is mannose-rich and
glycosylated, because it was sensitive to treatment with endo H and
converted to the nascent unglycosylated 90-kDa polypeptide. The nascent
90-kDa translation product was therefore exposed to the glycosylation
machinery in the lumen of the microsomal membranes. To investigate the
presence of cotranslationally formed disulfide bonds, the translation
reaction was carried out in the presence of oxidized glutathione
(GSSG). GSSG oxidizes existing thiol groups and facilitates, therefore,
the formation of disulfide bonds. It is required in the reaction
mixture to compensate for the presence of the reducing agent
dithiothreitol in the commercially prepared reticulocyte lysates. 2 or
6 mM GSSG was added to the reticulocyte lysates before
initiation of translation to obtain a lysate that was competent in
forming disulfide bonds in the newly synthesized protein. A change in
the thiol/disulfide redox status of the translation products has been
shown to influence the migration pattern of many proteins (37). In the
absence of GSSG and under non-reducing conditions, both the 90-kDa as
well as the glycosylated 100-kDa polypeptides could be detected (Fig.
4B). On the other hand, the addition of GSSG to the
translation mixture results in a substantial increase in the mobility
of the microsomal form of LPH from a 100-kDa species to one of ~70
kDa under non-reducing conditions. The faster migration behavior of
LPH through the gel matrix is reminiscent of a compact conformation
of this form facilitated by the formation of intramolecular disulfide
bonds in the presence of GSSG. The primary sequence of LPH contains
11 cysteine residues as putative candidates for the formation of
disulfide bridges, and the obvious mobility shift observed implies that
more than one disulfide bond might be formed to reach that high degree
of condensation.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 4.
Cell-free synthesis of
LPH . A, LPH was synthesized
in the presence or absence of microsomal membranes (MM) and
in the presence of varying concentrations of the oxidant GSSG as
indicated (B). The microsomal membranes were isolated by
centrifugation through a sucrose cushion and treated with endo H or not
treated. The samples were finally analyzed by SDS-PAGE on 8% slab gels
followed by autoradiography. For non-reducing conditions (B)
the samples were treated with 100 mM iodoacetamide and
loaded on 8% SDS-PAGE. A compact form of LPH that migrates faster
through the gel is indicated by asterisks.
|
|
LPH Resides in the ER of Transfected COS-1 Cells--
We
further analyzed the structural features of LPH in vivo
after expression in COS-1 cells. LPH was immunoprecipitated from biosynthetically labeled transfected cells with the polyclonal antibody
V496, which binds to the N-terminal part of LPH (30), followed by
treatment of the immunoprecipitates with endo H or endo F/GF. Fig.
5A shows that three forms of
LPH were revealed. A major 100-kDa component similar to the
N-glycosylated polypeptide was synthesized in the cell-free
system and two minor 103- and 97-kDa polypeptides. All three forms were
converted to the non-glycosylated 90-kDa species upon
N-deglycosylation with either endo H or endo F/GF,
indicating that they correspond to various glycosylated isoforms of the
same polypeptide. Furthermore, by virtue of the specificity of endo H
in cleaving mannose-rich N-glycans and endo F/GF in cleaving
mannose-rich as well as complex N-linked glycans, the data
indicate that LPH is exclusively mannose-rich and glycosylated and
is consequently located in the ER and is not further transported to the
Golgi apparatus.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 5.
LPH is blocked in
the ER. A, COS-1 cells were transiently transfected
with pcDNA3-LPH and labeled with [35S]methionine
for 6 h. Following cell lysis, LPH was immunoprecipitated with
pAb V496. The immunoprecipitates were further treated with endo H, endo
F/GF, or not treated and analyzed by SDS-PAGE and autoradiography.
B, for confocal studies COS-1 cells were transiently
transfected with pLPH -YFP followed by 48-h incubation at 37 °C. A
confocal analysis of the cells was performed in a Leica TCS-SP2
microscope, which indicated a strong ER-specific staining. Scale
bar, 20 µm.
|
|
These findings were corroborated by confocal microscopic analyses of
COS-1 cells expressing the yellow fluorescence protein (YFP) fused to
LPH (LPH -YFP). The transfected cells revealed exclusive labeling
of the ER (Fig. 5B).
LPH initial Polypeptide Acquires Enzymatic Activity
and Trypsin-resistant Conformation in the Presence of
LPH --
Having assessed the structural features of
LPH initial and LPH individually we wanted next to
examine directly the role of LPH on the folding of
LPH initial. One approach is to examine whether the
enzymatic activity of LPH initial increases in the presence of LPH reminiscent of acquisition of correct folding. For
this, COS-1 cells were cotransfected with the cDNAs encoding LPH initial and LPH . In the control cells
LPH initial was individually expressed. As shown above,
the enzymatic activity of LPH initial expressed alone in
cells cultured at 37 °C was very low, whereas this protein was
enzymatically active only at the permissive temperature of 20 °C
(Table I). On the other hand, the cotransfected cells reveal a dramatic
elevation in the enzymatic activity of LPH initial.
In the second approach the conformation of LPH initial in
the presence or absence of LPH was probed with trypsin to determine whether alterations in the folding pattern have occurred.
LPH initial was expressed in COS cells alone or in the
presence of LPH . The biosynthetically labeled proteins were
immunoprecipitated with mAb anti-LPH and treated with trypsin or with
V496, the polyclonal anti-LPH antibody. Fig.
6 shows that in the absence of
cotransfected LPH almost half of the LPH initial was
cleaved by trypsin to a smaller polypeptide pair corresponding to the
mannose-rich and complex-glycosylated forms. Immunoprecipitation of the
cellular lysates with V469, the anti-LPH antibody, was utilized as
an internal control to confirm the absence of this protein in this experimental set up. On the other hand, coexpression of
LPH initial with LPH leads to a substantial decrease
in the proportion of LPH initial cleaved by trypsin to
less than 10% reminiscent of an increased stability of this protein.
The presence of the LPH protein was confirmed by it reactivity with
the V496 antibody. It is established that the 160-kDa wild type
brush-border LPH is trypsin-resistant (25). That a complete
resistance of LPH initial to trypsin has not been
achieved is most likely due to the heterogeneous transfected cell
populations, which contained both genes, or the individual ones, and
therefore an optimal effect on LPH initial could be
attained. This is also the reason why the enzymatic activity could not
be fully restored to normal brush-border levels.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 6.
Trypsin treatment of
LPH initial isolated from COS-1
cells. COS-1 cells were transiently transfected with
pJB20-LPH initial in the presence or absence of
pcDNA3-LPH . 48 h after transfection the cells were labeled
with [35S]methionine for 8 h. The immunoprecipitated
LPH initial was treated with trypsin for 10 min at
37 °C. The reaction was stopped by the addition of soybean trypsin
inhibitor followed by boiling in SDS-PAGE sample buffer. The samples
were finally analyzed by SDS-PAGE on 6% slab gels and
autoradiography.
|
|
Finally, a significantly higher proportion of the complex-glycosylated
species in the total synthesized LPH initial protein was
detected in presence of LPH as compared with that of the individually expressed LPH initial (69.8%
versus 79.2%). This increase suggests a more efficient
processing and transport rate of mannose-rich LPH initial
as a consequence of altered folding characteristics in the presence of
LPH .
In conclusion, LPH initial is a temperature-sensitive
protein that is characterized by an improperly folded,
trypsin-sensitive, and biologically inactive protein at 37 °C.
Normal structural and functional features could be restored either at
20 °C or by addition of the prodomain LPH , indicating that these
N-terminal 734 amino acids of the proregion would assist the folding of
LPH initial at 37 °C.
LPH Is Associated with LPH initial When Expressed
in COS-1 Cells--
Having assessed the role of LPH on
LPH initial, we wanted to determine how this effect
ensues and whether there is a direct interaction between the two
proteins in the ER, where the most crucial folding events take place.
For this, LPH initial and LPH were coexpressed in
COS-1 cells and each protein was immunoprecipitated from the detergent
extracts of biosynthetically labeled cells, either with mAb anti-LPH
antibody, directed against LPH initial, or pAb V496
antibody directed against the LPH . Fig.
7A demonstrates that both
species coimmunoprecipitated with either antibody despite the specific
affinity of the antibodies used toward a particular epitope found on
the individual subunits and not on both. The question that arises is
whether the association between both subunits of pro-LPH results in the
attainment of a native conformation of LPH initial. This
is indeed the case, because there is an increase in the proportion of
LPH initial/c due to the presence of LPH in
trans and its direct association after biosynthesis with
LPH initial. The low amount of LPH coprecipitating
with LPH is compatible with a transient interaction occurring
between these two forms that is terminated as soon as the LPH
protein has acquired a correct conformation. Moreover, this interaction
appears to be specific to LPH, because the LPH prosequence is not
capable of modulating the folding of the isomaltase or sucrase subunits
of the sucrase-isomaltase enzyme
complex.2 Neither the
isomaltase nor the sucrase subunits are correctly folded species when
they are individually expressed, and they require each other to be
transported along the secretory pathway. Here the presence of the
LPH could not substitute for the role of either subunit in the
folding process of the other.

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 7.
Association of LPH
and LPH initial in the ER
elevates the proportion of complex-glycosylated
LPH initial. A,
coprecipitation of LPH and LPH initial. COS-1
cells were transiently transfected with pcDNA3-LPH and
pJB20-LPH initial and labeled 48 h post transfection
with [35S]methionine for 8 h. The cell lysates were
immunoprecipitated with mAb directed against the mature LPH
molecule. As a control, the supernatants were subsequently
immunoprecipitated with V496 directed against the LPH -propeptide.
Immunoprecipitated samples were further analyzed on SDS-PAGE and
autoradiography. B, confocal analysis of
LPH initial-CFP and LPH -YFP. COS-1 cells were
transfected with pLPH initial-CFP (blue) in
the absence (a) or presence of LPH -YFP
(yellow) (b-d). Expression of
LPH initial-CFP alone (a) results in an
ER-specific staining. After cotransfection with pLPH -YFP, the
LPH initial-CFP molecules (b) were further
transported to the Golgi apparatus with arrows indicating
transport vesicles. LPH -YFP is shown in c, and an
overlay of b and c is presented in
d (LPH -YFP in yellow,
LPH initial-CFP in blue). (Scale
bars: a, 10 µm; b-d, 20 µm.) The
arrows show transport vesicles containing
LPH initial-CFP when expressed in the presence of
LPH -YFP.
|
|
To visualize the effect of LPH on LPH in life cells, the two
proteins were fused either to the cyan fluorescent protein, CFP
(LPH initial-CFP), or the yellow fluorescent protein, YFP (LPH -YFP). Confocal microscope imaging of transfected COS-1 cells revealed a predominant ER localization of the
LPH initial-CFP (Fig. 7B, panel a).
On the other hand, when both subunits, LPH -YFP and
LPH initial-CFP, were coexpressed in the same cell,
LPH initial-CFP could be localized in the Golgi
apparatus, in transport vesicles and also at the cell surface (Fig.
6B, panels b-d). Here, both species were
expressed at virtually similar levels as assessed by quantification of
the specific fluorescence, excluding an imbalanced expression of the
subunits. In the absence of LPH -YFP no significant labeling of
LPH initial-CFP in the Golgi or at the cell surface could be observed (Fig. 7B, panel a). Together,
these observations support the biochemical data, which showed that the
individual expression of LPH results in a smaller proportion of
mature and complex-glycosylated LPH as compared with wild type
pro-LPH and LPH coexpressed with LPH (see Table
II, Fig. 6, and Ref. 30).
View this table:
[in this window]
[in a new window]
|
Table II
Processing of LPH initial to a complex glycosylated protein
increases in the presence of LPH
COS-1 cells were transiently transfected with
pJB20-LPH initial alone or in combination with
pcDNA3-LPH and incubated at 37 °C for 48 h. After pulse
labeling for 1 h with [35S]methionine and a chase of
4 h, LPH initial was immunoprecipitated and analyzed by
SDS-PAGE on 6% slab gels and fluorography. Results of densitometric
scanning are the mean ± S.E. of five experiments.
|
|
The ER-resident Molecular Chaperones BiP and Calnexin Assist the
Folding of LPH --
The trans effect of LPH on the
folding of LPH initial has lead us to ask how this effect
would associate and conform with other folding events that implicate ER
components, such as BiP and calnexin (38). The putative and temporal
interaction of LPH initial with BiP and calnexin was
analyzed in transiently transfected COS-1 cells either expressing
LPH initial alone or in addition of LPH . A pulse-chase
analysis of these cells followed by coprecipitation of chaperone-bound
LPH initial with anti-BiP and anti-calnexin antibodies is
demonstrated in Fig. 8. After a pulse
period of 10 min the mannose-rich polypeptide of individually expressed
LPH initial (i.e. in the absence of LPH )
could be found associated with BiP, but not calnexin. Essentially a
reversed binding pattern was obtained within 30 min of chase. Here,
LPH initial bound to calnexin and only slightly to BiP.
The same pattern was also revealed after 60 min of chase. Later, at 120 min of chase, however, the earliest binding profiles of
LPH initial to the two chaperones were repeated,
i.e. strong binding to BiP and almost negligible or no
binding to calnexin. Obviously LPH initial is subject to
several cycles of association, dissociation, and reassociation with
ER-resident proteins. Each of these cycles commences with the binding
of BiP to an early folding intermediate of LPH initial followed by its dissociation and the association with calnexin, which
in turn dissociates followed by the reassociation of BiP. The prolonged
period of binding to these two chaperones to LPH initial at virtually similar intensities throughout is presumably due to an
inefficient folding of LPH initial.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 8.
Sequential interaction of
LPH initial with BiP and
calnexin. COS-1 cells were transfected with a combination of
pcDNA3-LPH and pJB20-LPH initial or
pJB20-LPH initial. 48 h post transfection, the cells
were labeled for 10 min followed by different chase intervals. The cell
lysates were immunoprecipitated with mAb anti-LPH and when indicated
with anti-BiP or anti-calnexin. The samples were analyzed on SDS-PAGE
and autoradiography.
|
|
The sequential pattern of association of LPH initial with
BiP and calnexin changes substantially when LPH initial
was coexpressed with LPH . Here, only BiP, but not calnexin, bound to
LPH initial. The labeling intensity of
LPH initial that was associated with BiP decreased
concomitantly with the appearance of complex-glycosylated forms (Fig.
8). In sum, the data demonstrate that the absence of the LPH
prodomain exposes binding sites for calnexin resulting in the retention
of partially folded forms of LPH initial by this chaperone and a repeated association with BiP. LPH , on the other hand, assists the folding of LPH initial to a
transport-competent form that leaves the ER for further transport to
the cell surface. At least in part, calnexin compensates for the
absence of LPH by retaining LPH initial until BiP
binds and the protein goes into a new folding cycle.
 |
DISCUSSION |
The initial intracellular proteolytic cleavage of intestinal
pro-LPH in the trans-Golgi network at
Arg734/Leu735 (22) is a major processing event
along the secretory pathway of this protein. The generated
LPH initial is sorted to the apical membrane, where it
undergoes another cleavage step by trypsin to generate the brush-border
LPH protein, LPH final (22, 23). Two independent studies
have previously provided strong evidence that individual expression of
sequences encoding brush-border LPH, i.e.
Arg867-Phe1927, result in a
transport-incompetent and enzymatically inactive protein (29, 30) thus
implicating the profragment in the folding events of pro-LPH as an
intramolecular chaperone.
In the present report we addressed the putative role of
LPH as an intramolecular chaperone as well as the interplay between this domain, the LPH initial, and two ER-resident
proteins. These data demonstrate that LPH initial is a
temperature-sensitive protein that folds properly to an active protein
at 20 °C but is misfolded and inactive under the physiological
temperature. The first folding steps of proteins destined for transport
along the secretory pathway occur in the ER, which harbors a folding
machinery comprising a battery of molecular chaperones. Two members of
this machinery, BiP and calnexin, interact with
LPH initial at the non-permissive temperature, whereby
this interaction follows a sequential pattern and most likely proceeds
for several cycles. The cycles of association, dissociation, and
reassociation with the chaperone and the longer residence of the
LPH initial protein in the ER are apparently not
sufficient for the attainment of the protein to a mature, transport-competent configuration. In fact, only a minor proportion of
this protein egresses the ER and acquires a complex type of glycosylation in the Golgi. Despite traversing the quality control machinery in the ER, these polypeptides are enzymatically inactive and
sensitive toward trypsin treatment. This is reminiscent of altered
folding that is also reflected by a variation in the
N-glycosylation pattern, particularly that of the sialic
acid content, as compared with the correctly folded protein. A dual
function of molecular chaperones in regulating the folding of proteins
has been described for many proteins. In contrast to
LPH initial, however, the proteins in these cases acquire
ultimately a correctly folded configuration. For example, the folding
of the G protein of the vesicular stomatitis virus is critically
dependent on the interaction of this protein with BiP and calnexin
(39), whereas the immunoglobulin chains interact with BiP and GRP94
(40). The assembly of the multitransmembrane domains of the cystic
fibrosis transmembrane conductance regulator (CFTR) protein in
the cytosol is facilitated through the sequential binding with the
chaperones hdj-2 and hsc-70 (41), and in the case of thyroglobulin the
interaction with molecular chaperones follows a precursor-product
relationship (42).
The defect in the folding pattern of
LPH initial at the non-permissive temperature can be only
overcome when the N-terminally located LPH is present. Here,
enzymatic activity as well as correct folding is restored. One of the
early examples of prodomains with a folding function as an
intramolecular chaperone is the prodomain of subtilisin (15, 43). After
maturation of the precursor molecule, this polypeptide is
proteolytically cleaved to generate the biologically active protease.
It can guide the folding of the inactive protein to an active protease
in vitro when added exogenously (17). Intramolecular
chaperone function has also been described for the prodomains of
activin A (44), transforming growth factor 1 (44), cathepsin C (45),
and type 1 matrix metalloproteinase (46). The 13.5-kDa N-terminal part
of cathepsin C folds spontaneously and rapidly to a compact monomer
with stable tertiary interactions (45). It is involved in the
sequential formation of disulfide linkages in the native protein. This
has also been observed for the 13-residue proregion of bovine
pancreatic trypsin inhibitor, which provides an intramolecular thiol
disulfide reagent capable of assisting and accelerating disulfide bond
formation in the native enzyme (47). In an oxidizing milieu such as
that of the ER the LPH domain assumes a compact configuration
stabilized by disulfide bridges that link several of the 11 cysteine
residues (see "Results")3
and facilitated by hydrophobic interaction of almost 45% of uncharged, non-polar amino acid residues that are likely to be oriented into the
interior space of this protein. These structural features are favored
by the electrophoretic behavior of the faster migrating oxidized LPH
on SDS gels as compared with the non-oxidized isoform as well as the
reduced N-glycosylation. Potential N-linked
glycosylation sites in proteins are usually more accessible to
glycosylation in unfolded proteins than their folded and compact
counterparts (48). In analogy with other profragments and by virtue of
its decisive function in the folding of LPH initial one
would assume that LPH facilitates the accurate formation of
disulfide bridges in the LPH initial domain, which are
indispensable for the correct folding and generation of a native
pro-LPH (32). Moreover, the direct binding of LPH to
LPH initial, as shown in the in vitro assays,
suggests that LPH could function to prevent misfolding, to permit an
autonomous folding of LPH initial, and to help generate disulfide bonds in the ER. It should be noted that the interaction of
the LPH prosequence is most likely specific to LPH, because it is
not capable of modulating the folding of the isomaltase subunit of the
sucrase-isomaltase enzyme complex. Here, neither the isomaltase nor the
sucrase subunits are competently transported along the secretory
pathway when they are individually expressed.
By virtue of the striking sequence similarities between LPH and
LPH initial it is likely that LPH builds a kernel
structure immediately after synthesis that functions as a folding
template for other homologous structural domains of
LPH initial. This would also explain why several cycles
of sequential interaction of LPH initial with the two
chaperones, BiP and calnexin, in the absence of LPH are not
sufficient for LPH initial to acquire correctly folded confirmation whereas the binding of LPH was.
Current concepts suggest that at least two additional mechanisms
specify the function of intramolecular chaperones, an unfolding of
misfolded conformations, and a nonspecific prevention of protein misfolding. The mode of action of LPH on the folding of
LPH initial provides an additional novel mechanism of
this type of domains.
The breakage of the cycles of sequential binding of
LPH initial to BiP and calnexin, in the presence of
LPH , prevent the interaction of LPH initial with
calnexin, suggesting that both polypeptides, LPH and calnexin,
compete in binding to common sites on LPH initial.
Nevertheless, calnexin by itself is not able to replace LPH , because
it does not share homologies with LPH initial as LPH
does and is therefore unable to behave as a folding template for
LPH initial.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Neil Bulleid, University of
Manchester, United Kingdom, Dr. Hans-Peter Hauri, Biozentrum,
University of Basel, Dr. Erwin Sterchi, Institute of Biochemistry and
Molecular Biology, University of Bern, Switzerland, and Dr. Dallas
Swallow, Medical Research Council, London, United Kingdom for generous
gifts of monoclonal anti-BiP, anti-calnexin, and anti-LPH antibodies.
 |
FOOTNOTES |
*
This work was supported by Grant Na 331/1-2 from the
Deutsche Forschungsgemeinschaft, Bonn, Germany and the
Sonderforschungsbereich 280.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 49-511-953-8780;
Fax: 49-511-953-8585; E-mail: Hassan.Naim@tiho-hannover.de.
Published, JBC Papers in Press, December 18, 2001, DOI 10.1074/jbc.M111500200
2
R. Jacob, B. Pürschel, and H. Y. Naim, manuscript in preparation..
3
R. Jacob, K. Peters, and H. Y. Naim,
unpublished observations.
 |
ABBREVIATIONS |
The abbreviations used are:
ER, endoplasmic
reticulum;
LPH, lactase-phlorizin hydrolase (all forms);
pro-LPH, uncleaved precursor of LPH;
mAb, monoclonal antibody;
pAb, polyclonal
antibody;
pro-LPHh, mannose-rich precursor;
pro-LPHc, complex-glycosylated precursor;
TX-100, Triton
X-100;
TEMED, N,N,N',N'-tetramethylenediamine;
DMEM, Dulbecco's modified Eagle's medium;
CFP, cyan fluorescence
protein;
YFP, yellow fluorescence protein;
GSSG, oxidized glutathione;
endo H, endo- -acetylglucosaminidase H;
endo F/GF, endo- -N-acetylglucosaminidase F/N-glucosidase
F;
BiP, immunoglobulin-binding protein.
 |
REFERENCES |
| 1.
|
Gething, M. J.,
and Sambrook, J.
(1992)
Nature
355,
33-45[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
von Heijne, G.
(1984)
J. Mol. Biol.
173,
243-251[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Welply, J. K.,
Shenbagamurthi, P.,
Lennarz, W. J.,
and Naider, F.
(1983)
J. Biol. Chem.
258,
11856-11863[Abstract/Free Full Text]
|
| 4.
|
Segal, M. S.,
Bye, J. M.,
Sambrook, J. F.,
and Gething, M. J.
(1992)
J. Cell Biol.
118,
227-244[Abstract/Free Full Text]
|
| 5.
|
Tatu, U.,
and Helenius, A.
(1997)
J. Cell Biol.
136,
555-565[Abstract/Free Full Text]
|
| 6.
|
Wilson, R.,
Lees, J. F.,
and Bulleid, N. J.
(1998)
J. Biol. Chem.
273,
9637-9643[Abstract/Free Full Text]
|
| 7.
|
Hurtley, S. M.,
and Helenius, A.
(1989)
Annu. Rev. Cell Biol.
5,
277-307[CrossRef]
|
| 8.
|
Hammond, C.,
and Helenius, A.
(1994)
J. Cell Biol.
126,
41-52[Abstract/Free Full Text]
|
| 9.
|
Ellgaard, L.,
Molinari, M.,
and Helenius, A.
(1999)
Science
286,
1882-1888[Abstract/Free Full Text]
|
| 10.
|
Ouwendijk, J.,
Moolenaar, C. E.,
Peters, W. J.,
Hollenberg, C. P.,
Ginsel, L. A.,
Fransen, J. A.,
and Naim, H. Y.
(1996)
J. Clin. Invest.
97,
633-641[Medline]
[Order article via Infotrieve]
|
| 11.
|
Chen, S. S.,
and Huang, A. S.
(1986)
J. Virol.
59,
210-215[Abstract/Free Full Text]
|
| 12.
|
Tatu, U.,
Hammond, C.,
and Helenius, A.
(1995)
EMBO J.
14,
1340-1348[Medline]
[Order article via Infotrieve]
|
| 13.
|
Jacob, R.,
Weiner, J. R.,
Stadge, S.,
and Naim, H. Y.
(2000)
J. Biol. Chem.
275,
10630-10637[Abstract/Free Full Text]
|
| 14.
|
Panzer, P.,
Preuss, U.,
Joberty, G.,
and Naim, H. Y.
(1998)
J. Biol. Chem.
273,
13861-13869[Abstract/Free Full Text]
|
| 15.
|
Barr, P. J.
(1991)
Cell
66,
1-3[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Steiner, D. F.,
Docherty, K.,
and Carroll, R.
(1984)
J. Cell. Biochem.
24,
121-130[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Zhu, X. L.,
Ohta, Y.,
Jordan, F.,
and Inouye, M.
(1989)
Nature
339,
483-484[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Mantei, N.,
Villa, M.,
Enzler, T.,
Wacker, H.,
Boll, W.,
James, P.,
Hunziker, W.,
and Semenza, G.
(1988)
EMBO J.
7,
2705-2713[Medline]
[Order article via Infotrieve]
|
| 19.
|
Skovbjerg, H.,
Danielsen, E. M.,
Noren, O.,
and Sjostrom, H.
(1984)
Biochim. Biophys. Acta
798,
247-251[Medline]
[Order article via Infotrieve]
|
| 20.
|
Hauri, H. P.,
Sterchi, E. E.,
Bienz, D.,
Fransen, J. A.,
and Marxer, A.
(1985)
J. Cell Biol.
101,
838-851[Abstract/Free Full Text]
|
| 21.
|
Naim, H. Y.,
Sterchi, E. E.,
and Lentze, M. J.
(1987)
Biochem. J.
241,
427-434[Medline]
[Order article via Infotrieve]
|
| 22.
|
Jacob, R.,
Radebach, I.,
Wuthrich, M.,
Grunberg, J.,
Sterchi, E. E.,
and Naim, H. Y.
(1996)
Eur. J. Biochem.
236,
789-795[Medline]
[Order article via Infotrieve]
|
| 23.
|
Wuthrich, M.,
Grunberg, J.,
Hahn, D.,
Jacob, R.,
Radebach, I.,
Naim, H. Y.,
and Sterchi, E. E.
(1996)
Arch. Biochem. Biophys.
336,
27-34[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Yeh, K. Y.,
Yeh, M.,
and Holt, P. R.
(1991)
Am. J. Physiol.
260,
G379-G384[Abstract/Free Full Text]
|
| 25.
|
Naim, H. Y.,
Lacey, S. W.,
Sambrook, J. F.,
and Gething, M. J.
(1991)
J. Biol. Chem.
266,
12313-12320[Abstract/Free Full Text]
|
| 26.
|
Grunberg, J.,
Luginbuhl, U.,
and Sterchi, E. E.
(1992)
FEBS Lett.
314,
224-228[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Jacob, R.,
Brewer, C.,
Fransen, J. A.,
and Naim, H. Y.
(1994)
J. Biol. Chem.
269,
2712-2721[Abstract/Free Full Text]
|
| 28.
|
Wacker, H.,
Keller, P.,
Falchetto, R.,
Legler, G.,
and Semenza, G.
(1992)
J. Biol. Chem.
267,
18744-18752[Abstract/Free Full Text]
|
| 29.
|
Oberholzer, T.,
Mantei, N.,
and Semenza, G.
(1993)
FEBS Lett.
333,
127-131[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Naim, H. Y.,
Jacob, R.,
Naim, H.,
Sambrook, J. F.,
and Gething, M. J.
(1994)
J. Biol. Chem.
269,
26933-26943[Abstract/Free Full Text]
|
| 31.
|
Maiuri, L.,
Raia, V.,
Potter, J.,
Swallow, D., Ho, M. W.,
Fiocca, R.,
Finzi, G.,
Cornaggia, M.,
Capella, C.,
and Quaroni, A.
(1991)
Gastroenterology
100,
359-369[Medline]
[Order article via Infotrieve]
|
| 32.
|
Jacob, R.,
Bulleid, N. J.,
and Naim, H. Y.
(1995)
J. Biol. Chem.
270,
18678-18684[Abstract/Free Full Text]
|
| 33.
|
Bulleid, N. J.,
and Freedman, R. B.
(1988)
Nature
335,
649-651[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Jacob, R.,
and Naim, H. Y.
(2001)
Curr. Biol.
11,
1444-1450[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Dahlqvist, A.
(1968)
Anal. Biochem.
22,
99-107[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Zecca, L.,
Mesonero, J. E.,
Stutz, A.,
Poiree, J. C.,
Giudicelli, J.,
Cursio, R.,
Gloor, S. M.,
and Semenza, G.
(1998)
FEBS Lett.
435,
225-228[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Goldenberg, D. P.,
and Creighton, T. E.
(1984)
Anal. Biochem.
138,
1-18[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
High, S.,
Lecomte, F. J.,
Russell, S. J.,
Abell, B. M.,
and Oliver, J. D.
(2000)
FEBS Lett.
476,
38-41[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Hammond, C.,
and Helenius, A.
(1994)
Science
266,
456-458[Abstract/Free Full Text]
|
| 40.
|
Melnick, J.,
Dul, J. L.,
and Argon, Y.
(1994)
Nature
370,
373-375[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Meacham, G. C., Lu, Z.,
King, S.,
Sorscher, E.,
Tousson, A.,
and Cyr, D. M.
(1999)
EMBO J.
18,
1492-1505[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Kim, P. S.,
and Arvan, P.
(1995)
J. Cell Biol.
128,
29-38[Abstract/Free Full Text]
|
| 43.
|
Inouye, M.
(1991)
Enzyme
45,
314-321[Medline]
[Order article via Infotrieve]
|
| 44.
|
Gray, A. M.,
and Mason, A. J.
(1990)
Science
247,
1328-1330[Abstract/Free Full Text]
|
| 45.
|
Cigic, B.,
Dahl, S. W.,
and Pain, R. H.
(2000)
Biochemistry
39,
12382-12390[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Cao, J.,
Hymowitz, M.,
Conner, C.,
Bahou, W. F.,
and Zucker, S.
(2000)
J. Biol. Chem.
275,
29648-29653[Abstract/Free Full Text]
|
| 47.
|
Weissman, J. S.,
and Kim, P. S.
(1992)
Cell
71,
841-851[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Allen, S.,
Naim, H. Y.,
and Bulleid, N. J.
(1995)
J. Biol. Chem.
270,
4797-4804[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. J. Propsting, H. Kanapin, R. Jacob, and H. Y. Naim
A phenylalanine-based folding determinant in intestinal sucrase-isomaltase that functions in the context of a quality control mechanism beyond the endoplasmic reticulum
J. Cell Sci.,
June 15, 2005;
118(12):
2775 - 2784.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R J Grand, R K Montgomery, D K Chitkara, and J N Hirschhorn
Changing genes; losing lactase
Gut,
May 1, 2003;
52(5):
617 - 619.
[Full Text]
|
 |
|

|
 |

|
 |
 
M. J. Propsting, R. Jacob, and H. Y. Naim
A Glutamine to Proline Exchange at Amino Acid Residue 1098 in Sucrase Causes a Temperature-sensitive Arrest of Sucrase-isomaltase in the Endoplasmic Reticulum and cis-Golgi
J. Biol. Chem.,
April 25, 2003;
278(18):
16310 - 16314.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nauze, L. Gonin, B. Chaminade, C. Peres, F. Hullin-Matsuda, B. Perret, H. Chap, and A. Gassama-Diagne
Guinea Pig Phospholipase B, Identification of the Catalytic Serine and the Proregion Involved in Its Processing and Enzymatic Activity
J. Biol. Chem.,
November 8, 2002;
277(46):
44093 - 44099.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Jacob, B. Purschel, and H. Y. Naim
Sucrase Is an Intramolecular Chaperone Located at the C-terminal End of the Sucrase-Isomaltase Enzyme Complex
J. Biol. Chem.,
August 23, 2002;
277(35):
32141 - 32148.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|